Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3917.00 | 3914.00 | 1.0008 | 1.0014 | |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3645.00 | 3914.00 | 0.9313 | 0.8715 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 2500.00 | 1861.36 | 2141.00 | 3914.00 | 0.5470 | 0.1394 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 2962.00 | 3914.00 | 0.7568 | 0.5423 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 3815.00 | 3914.00 | 0.9747 | 0.9528 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 4011.00 | 3914.00 | 1.0248 | 1.0462 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 4182.00 | 3914.00 | 1.0685 | 1.1274 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 2397.00 | 3914.00 | 0.6124 | 0.2660 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4019.00 | 3914.00 | 1.0268 | 1.0500 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 2500.00 | 1861.36 | 4022.00 | 3914.00 | 1.0276 | 1.0514 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4095.00 | 3914.00 | 1.0462 | 1.0861 | |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 4205.00 | 3914.00 | 1.0743 | 1.1383 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 2500.00 | 1861.36 | 1873.00 | 3914.00 | 0.4785 | 0.0058 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 3236.00 | 3914.00 | 0.8268 | 0.6749 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 1903.00 | 3914.00 | 0.4862 | 0.0208 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 1612.00 | 3914.00 | 0.4119 | -0.1255 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 4059.00 | 3914.00 | 1.0370 | 1.0690 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3883.00 | 3914.00 | 0.9921 | 0.9852 | |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 2500.00 | 1861.36 | 1905.00 | 3914.00 | 0.4867 | 0.0218 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 2458.00 | 3914.00 | 0.6280 | 0.2960 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 2500.00 | 1861.36 | 3720.00 | 3914.00 | 0.9504 | 0.9074 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 2242.00 | 3914.00 | 0.5728 | 0.1895 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3837.00 | 3914.00 | 0.9803 | 0.9633 | |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5695.00 | 5870.50 | 0.9701 | 0.9172 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5615.00 | 5870.50 | 0.9565 | 0.8797 |